论文部分内容阅读
本文目的是为帮助正确理解第69届世界卫生大会“促进创新和获取优质、安全、有效和可负担的儿童药物”决议内容、制定政策和推进工作提供借鉴和参考。本文描述性地介绍决议提出背景和通过过程,解读决议内容。“促进创新和获取优质、安全、有效和可负担的儿童药物”决议获世界卫生大会通过,代表了中国在促进儿童这一最脆弱人群的基本医疗服务的国际话语权;彰显了中国的大国责任和风范;既是对中国新医改工作的有利促进和对千年目标实现的有效推进,也是中国对全球儿童健康事业的巨大贡献。
The purpose of this article is to provide a reference for the correct understanding of the resolutions of the 69th World Health Assembly, “Promoting Innovativeness and Access to Quality, Safe, Effective and Affordable Children’s Drugs” and to formulating policies and advancing work. This article describes the background of the resolution and the adoption of the process to interpret the resolution. The resolution “Promoting Innovativeness and Access to Quality, Safe, Effective and Affordable Children’s Medicine”, adopted by the World Health Assembly, represents the international voice of China in promoting basic medical services for the most vulnerable group of children; demonstrates China’s The responsibility and demeanor of the great powers are both a favorable promotion of the new medical reform in China and an effective promotion of the achievement of the Millennium Goals and a great contribution made by China to the cause of global child health.